Nitroglycerin (generic), Nitrostat Newswire

Nitroglycerin (generic), Nitrostat Newswire

Comprehensive Real-Time News Feed for Nitroglycerin (generic), Nitrostat.

Results 1 - 20 of 54 in Nitroglycerin (generic), Nitrostat

  1. Bad Hip Isn't Always PainfulRead the original story w/Photo

    Mar 24, 2016 | Genesee Valley Pennysaver

    DEAR DR. ROACH: It would be helpful if you described some of the warning signs/symptoms of a bad hip that requires replacement.

    Comment?

  2. a Hea d be dead:a Heart attack victim saved by doctors working at marathon tentRead the original story w/Photo

    Saturday Mar 4 | Bellingham Herald

    Doctors stationed at the Cowtown Marathon last week helped save a man's life - but he wasn't there for the race. Joel King, 56, of Joshua, was working Sunday morning at the Will Rogers Memorial Center, where his family's business, Metro Golf Cars, had provided carts for a horse show the day before.

    Comment?

  3. Heart attacks: Knowing the risks, the signs, the steps to takeRead the original story w/Photo

    Feb 17, 2017 | NewsOK.com

    Many people who experience a heart attack have warning signs hours, days or weeks in advance. - Call 911 or your local medical emergency number.

    Comment?

  4. 5 of the most powerful non-nuclear explosives everRead the original story w/Photo

    Feb 17, 2017 | Silicon Alley Insider

    The chemical, tri-cyclic acetone peroxide, or TATP, was made by accident as the product of a chemistry experiment. But although the TATP in question came as an unwelcome surprise - the Ministry of Defence was forced to carry out a controlled disposal - there are many labs around the world which do design and make explosives for interest and application.

    Comment?

  5. Management of Coronary Artery Disease and Chronic Stable AnginaRead the original story w/Photo

    Feb 16, 2017 | US Pharmacist

    ABSTRACT: Coronary artery disease is the most common type of heart disease and the leading cause of death worldwide. Angina pectoris , a clinical syndrome characterized by discomfort typically located in the chest, neck, or left arm, is one of several clinical manifestations of CAD.

    Comment?

  6. ACC/AHA Guidelines for the Management of Patients With ST-Elevation...Read the original story

    Aug 3, 2004 | Circulation

    A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Although considerable improvement has occurred in the process of care for patients with ST-elevation myocardial infarction , room for improvement exists. 1-3 The purpose of the present guideline is to focus on the numerous advances in the diagnosis and management of patients with STEMI since 1999.

    Comment?

  7. Prognostic Impact of Coronary Vasodilator Dysfunction on Adverse...Read the original story

    Apr 25, 2000 | Circulation

    Endothelial vasodilator dysfunction is a characteristic feature of patients at risk for coronary atherosclerosis. Therefore, we prospectively investigated whether coronary endothelial dysfunction predicts disease progression and cardiovascular event rates.

    Comment?

  8. Long-Term Follow-Up of Patients With Mild Coronary Artery Disease and Endothelial DysfunctionRead the original story

    Mar 7, 2000 | Circulation

    Coronary endothelial dysfunction is characterized by vasoconstrictive response to the endothelium-dependent vasodilator acetylcholine. Although endothelial dysfunction is considered an early phase of coronary atherosclerosis, there is a paucity of information regarding the outcome of these patients.

    Comment?

  9. Quick action is critical if having a heart attackRead the original story w/Photo

    Feb 13, 2017 | The Columbian

    A heart attack generally causes chest pain for more than 15 minutes, but it can also have no symptoms at all. Many people who experience a heart attack have warning signs hours, days or weeks in advance.

    Comment?

  10. Tackling Heart Health Head On: One Woman's Journey to Coronary Artery Disease Diagnosis and TreatmentRead the original story w/Photo

    Feb 12, 2017 | The Gillette News-Record

    The American Heart Association estimates that Dukes is just one of the 15 million Americans affected by CAD. The disease causes the blood vessels that feed the heart to become narrow, making it difficult for blood to flow to the heart, according to the Heart Foundation.

    Comment?

  11. Some good reasons to be cautious about using dietary supplementsRead the original story w/Photo

    Feb 10, 2017 | The Washington Post

    You might think that dietary supplements offer a safer, more natural alternative to medication for problems such as high cholesterol. But "some contain ingredients that are really drugs," says Marvin M. Lipman, Consumer Reports' chief medical adviser.

    Comment?

  12. Taxus Cardium Release: FDA Grants Fast Track Designation To...Read the original story

    Feb 6, 2017 | BioSpace

    Taxus Cardium Release: FDA Grants Fast Track Designation To Angionetics' Generx Product Candidate, A One-Time Gene Therapy For Coronary Heart Disease /PRNewswire/ -- Angionetics Inc., a majority-owned subsidiary of Taxus Cardium Pharmaceuticals Group Inc. , today reported that the FDA has granted Fast Track designation for the Phase 3 clinical investigation of Generx [Ad5FGF-4] cardiovascular angiogenic gene therapy as a one-time treatment for improving exercise tolerance in patients who have angina that is refractory to standard medical therapy and not amenable to conventional revascularization procedures . For more information please visit www.angionetics.com and www.MyRefractoryAngina.com .

    Comment?

  13. Renova Therapeutics Enters Into Agreement To Receive Stresscopin...Read the original story

    Feb 5, 2017 | BioSpace

    Renova Therapeutics, Inc., a biotechnology company developing gene therapy treatments for congestive heart failure and type 2 diabetes, announced today that it has entered into an agreement with Janssen Pharmaceuticals, Inc., whereby the investigational new drug file for stresscopin a hormone involved in responses to physiological stress will be transferred from Janssen, where it was previously under development. Renova Therapeutics plans to advance development of the stresscopin program as RT-400, a peptide infusion treatment for episodes of Acute Decompensated Heart Failure .

    Comment?

  14. Emergency Medicine: Quick response vital in treating heart attacksRead the original story w/Photo

    Feb 5, 2017 | The Columbus Dispatch

    As the recent Ohio State-Michigan football came to an exciting and dramatic finale, I sat in the emergency department anticipating the influx of patients who would soon arrive. There is speculation - although no definitive studies prove it - that the risk of heart attack is greater after highly emotional events such as a thrilling Buckeyes game or the Super Bowl.

    Comment?

  15. A Potentially Lethal HeadacheRead the original story w/Photo

    Jan 24, 2017 | BellaOnline

    Headaches are a very common problem that practically everyone has experienced at some point in time. Fortunately, the vast majority of headaches are benign; they are annoying and may be very painful, but they are not dangerous and cause no lasting harm.

    Comment?

  16. GONITROa to Participate in First-of-its-Kind Comparative...Read the original story

    Jan 19, 2017 | Customer Interaction Solutions

    GONITRO to Participate in First-of-its-Kind Comparative Effectiveness ISCHEMIA Clinical Trial Sponsored by the National Institutes of Health Espero Pharmaceuticals, Inc., a commercial-stage cardiovascular pharmaceutical company, will donate GONITRO to the ongoing International Study of Comparative Health Effectiveness with Medical and Invasive Approaches clinical trial and to the ISCHEMIA-Chronic Kidney Disease ancillary trial. The company's executives provided an update during last week's annual JP Morgan Healthcare Conference in San Francisco, California.

    Comment?

  17. Espero Pharma Release: GONITRO To Participate In First-Of-Its-Kind...Read the original story

    Jan 18, 2017 | BioSpace

    Espero Pharmaceuticals, Inc., a commercial-stage cardiovascular pharmaceutical company, will donate GONITROa to the ongoing International Study of Comparative Health Effectiveness with Medical and Invasive Approaches clinical trial and to the ISCHEMIA-Chronic Kidney Disease ancillary trial. The company's executives provided an update during last week's annual JP Morgan Healthcare Conference in San Francisco, California.

    Comment?

  18. Nazi-melting chemicals or paw-safe granules? Your callRead the original story w/Photo

    Jan 6, 2017 | Star Tribune

    Sometimes you take the old tried-and-true approach when the steps are icy: one at a time, with great care, as if you are carrying FabergA eggs loaded with nitroglycerin. Sometimes, however, you move a little too fast, and you have that reaction a pilot gets when the fog clears and there's a mountain range in the window.

    Comment?

  19. Expired Meds: Are Those Old Pills In Your Medicine Chest Still Good?Read the original story w/Photo

    Jan 4, 2017 | News Max

    Do you have a few bottles of Advil or Tylenol lying around that are older than the family pet? If it's been a few years since you've cleaned out your medicine cabinet, there's a few things you should know medical expiration dates. "There isn't a 'magic date' for most over-the-counter medications," says Ana Ondrizek, a clinical pharmacist at Jackson Medical Center for Longterm Care in Miami.

    Comment?

  20. Microvascular Angina: a Puzzling Form of Chest Pain and Unrecognized DangerRead the original story

    Dec 30, 2016 | US News & World Report

    A type of cardiovascular disease known to physicians as microvascular angina affects the heart's tiniest arteries and causes chest pain . The disease is sneaky, in that it doesn't show up on traditional heart scans but is linked to serious health outcomes, like heart attacks.

    Comment?